Orlando, Fla.
Rotech Healthcare is shifting its focus from turnaround activities to growing revenue and patient care, the company announced last month.
The respiratory giant — which emerged from bankruptcy in 2003 — now has a “competitive cost structure in the marketplace” and has outlined a revenue growth plan based on several initiatives:
-
Internal growth — The sales force of 400 has been restructured so the company can commit more time to selling and less to hiring and training new employees.
-
New clinical programs — Rotech is expanding its base of respiratory therapists.
-
Medicare Part B drugs — A new pharmacy in Kentucky handles dispensing and distribution of all drug reorders.
-
Acquisitions — Plans call for spending approximately $30 million to pursue small acquisitions during 2005.
-
New branches — A “modest” number are expected to open this year.
-
Managed care — More resources are being put into this area, which Rotech expects to grow at a higher rate than its Medicare business.
The 500-branch company will conduct a campaign about its new focus for referral sources and patients using the phrase “We Care About Patient Care.”
